Meet the 2018 June Land O’ Lakes Speakers

I have worked on various aspects of continuous manufacturing (CM) for the last five years culminating in Lilly’s first approved CM product! I will be talking about formulation development with continuous direct compression as well as commercialization of a CM drug product at the June 2018 Land O’Lakes Conference on June 6th. I am excited to present and discuss these topics because CM is still relatively new to the pharmaceutical industry and there is a great opportunity for collaboration and learning. I look forward to seeing you in Madison in early June!

Wyatt Roth
Senior Research Scientist
Small Molecule Design and Development
Eli Lilly & Company

I will be talking about Formulation and Process Development for PCMM Direct Compression Continuous Manufacturing Process at the June 2018 Land O Lakes Conference on Wednesday, June 6th. I am really excited to be presenting this topic because it has been a new and challenging area of research and development over the last few years. I look forward to seeing you there.

Patrick Daugherity
Principal Scientist
Drug Product Design
Pfizer

My research work lies at the drug substance-drug product interface focusing on crystal polymorphism, the solid form selection process, and particle engineering to enable the design of robust drug products. I will be talking about co-processing of active pharmaceutical ingredients (APIs) with excipients at the 2018 Land O Lakes Conference on June 5th. I am really excited to be presenting about this topic because poor API powder properties are one of the most common problems that challenge successful manufacture of high-quality tablet products, especially for high-dose drug formulations. Co-processing of API with excipients can significantly improve the functional properties to overcome these challenges and can be a potential particle engineering approach to enable continuous tablet manufacturing. I look forward to seeing you there.

Deniz Erdemir
Principal Scientist
Bristol-Myers Squibb

I will be talking about the development of the manufacturing process for a continuously wet granulated FDC tablet at the June 2018 Land O Lakes Conference on Wednesday, June 6th. I am excited to share the learnings gained from the development process and discuss solutions to challenges within continuous manufacturing!

Steven Dale
Formulation Development Scientist
Vertex Pharmaceuticals

I lead our flow chemistry efforts. I will be talking about how we use flow to enable the efficient synthesis of our API at the “June 2018 Land O Lakes Conference” on June 5th. I am really excited to be presenting about this topic because I believe that when implemented appropriately continuous processes such as flow chemistry and immobilized biocatalysis can provide benefits in cost, safety, robustness or speed, and that this will allow us to develop and deliver medicines to patients better, faster and cheaper. I look forward to seeing you there.

John Naber
Director of Process Research & Development
Merck & Co.

I will be talking about the development and implementation of continuous manufacturing for small molecule drug substance at the 2018 Land O Lakes Conference on Tuesday 5th June. I am excited about sharing my own experiences in this area as I’ve worked both on the development and manufacturing side. What is more, I am delighted to present our most recent achievement: the first small volume continuous manufacturing campaign in our new continuous facility in Ireland. I look forward to seeing you there.

Sarah O’Keefe
Small Molecule Design and Development
Eli Lilly & Company